Why Novo Nordisk Stock Popped Again Today
Novo Nordisk (NYSE: NVO) -- the original Ozempic stock -- jumped higher again Thursday after announcing results from a weight loss study that had patients taking its Wegovy GLP-1 weight loss drug orally instead of via injection.
Novo Nordisk stock is up 6.5% through 12:25 p.m. ET.
Image source: Getty Images.
Source Fool.com